Concepedia

Dimitrios Korentzelos

DK

Statistics

Publications

8

Citations

621

H-Index

8

Active since

2017

Affiliations

University of Pittsburgh Medical Center(Current)

The University of Texas MD Anderson Cancer Center

University of Pittsburgh

UPMC Hillman Cancer Center

Dimitrios Korentzelos is an author at University of Pittsburgh Medical Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2017–2022

8

Publications

8

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Likun Li, Styliani Karanika, Guang Yang et al. · Science Signaling · 2017 · 304 citations

, , +17

Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate Cancer

Bo Liu, Wenhui Wu, Likun Li et al. · Clinical Cancer Research · 2017 · 108 citations · Full text

, , +17

PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer

Bo Liu, Likun Li, Guang Yang et al. · Clinical Cancer Research · 2019 · 77 citations · Full text

, , +17

Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models

Yong Luo, Abul Kalam Azad, Styliani Karanika et al. · International Journal of Cancer · 2017 · 50 citations · Full text

, , +17

Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms

Susana Jorge, José Luís Capelo, William A. LaFramboise et al. · BMC Medicine · 2021 · 25 citations · Full text

, , +17

1–5 of 8